This protocol addresses episcleritis managed with a systemic oral anti-inflammatory approach. The full regimen specifies agent selection and clinical guidance for this indication.
Management centres on oral nonsteroidal anti-inflammatory therapy. The complete protocol — including the specific agent, sequencing, and clinical follow-up criteria — is available via the link below.
DOI: 10.1016/S0002-9394(00)00710-8
If topical corticosteroids failed, patients with episcleritis were treated with oral nonsteroidal anti-inflammatory drugs, most often indomethacin.
View source ↗